Telepathology Market Size & Share 2023 to 2032
Market Size by Product (Scanner, Communication System, Storage System), by Application (Teleconsultation, Drug Discovery, Disease Diagnosis), by End Use (Hospitals.
Report ID: GMI6207
|
Published Date: July 2023
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Pratiksha Kamthe
Telepathology Market Size
Telepathology Market size was valued at USD 656 million in 2022 and is estimated to account for USD 2.1 billion by 2032. Telepathology refers to the practice of remotely accessing and interpreting pathology images, such as in tissue diagnostics, using telecommunication technology.
Telepathology Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
It involves the digital capture and transmission of high-resolution images, enabling pathologists to review and diagnose cases from a distance. Telepathology facilitates consultation, second opinions, and collaboration among pathologists, overcoming geographical barriers and enhancing access to pathology expertise. Telepathology adopts artificial intelligence in medical imaging and thereby offers the potential for timely and accurate diagnosis, particularly in developing regions wherein physical access to pathology laboratory equipment and services is limited.
Additionally, increasing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and diabetes. For instance, as per the World Health Organization (WHO), there are approximately 41 million deaths due to non-communicable diseases (NCDs), annually, accounting for around 74% of total deaths. Furthermore, around 17 million individuals die prematurely from NCDs, with low- and middle-income countries bearing the brunt. Additionally, there is a growing recognition of the benefits associated with telehealth, including telepathology. Patients are becoming more aware of the convenience and accessibility offered by telemedicine, and healthcare providers are increasingly embracing teleconsultation as a means to expand their reach and improve patient care.
COVID-19 Impact
The COVID-19 pandemic significantly impacted the telepathology market. It led to increased adoption of telepathology services, ensuring continuity of pathology care while minimizing infection risks. Telepathology facilitated the diagnosis and triage of COVID-19 cases, enabled remote consultations and collaborations among pathologists, supported education and training programs. For instance, telepathology played a vital role in continuing education and training programs for pathologists during the pandemic. Virtual conferences, webinars, and online platforms allowed for knowledge sharing, case discussions, and skill development. The pandemic accelerated the acceptance and integration of telepathology into standard practices, with long-term implications for its continued utilization.
Telepathology Market Trends
The telepathology industry is witnessing significant research and development activities aimed at improving technology, enhancing image analysis algorithms, and integrating artificial intelligence (AI) capabilities. Researchers are continually working to develop advanced digital imaging systems, whole slide imaging system, and image analysis tools that offer higher resolution, improved image quality, and better accuracy in diagnosing various diseases. For instance, the NanoZoomer System was made by Hamamatsu to help pathologists in reviewing and interpreting digital pictures of surgical pathology slides made from formalin-fixed paraffin-embedded ("FFPE") tissue which is designed for in vitro diagnostic application. Additionally, increasing funding by public and private sector often aims to enhance telecommunication networks, expand access to digital pathology platforms, and promote collaboration between pathologists and telepathology service providers.
Telepathology Product Market Analysis
The telepathology market by product is categorized into scanner, communication system, and storage system. The scanner segment garnered USD 368.3 million revenue size in the year 2022. Scanners play a crucial role in telepathology by capturing high-resolution images of the specimens and transmitting them to pathologists for remote interpretation. Scanners, such as whole slide imaging (WSI) scanners, slide scanners, portable scanners, and microscopy systems including virtual microscopes. They enable the digitization of pathology specimens, facilitating remote access, efficient transmission, and collaborative diagnostics. Scanners enhance accessibility, workflow efficiency, and improve patient care outcomes in telepathology.
Based on application, the telepathology market is segmented into teleconsultation, drug discovery, disease diagnosis, and others. The teleconsultation segment is anticipated to witness high growth at 12.8% by 2032. Teleconsultation will drive the telepathology business by leveraging advanced technology to remotely review and diagnose digital pathology images. It will also help to overcome geographical barriers, ensuring access to specialized expertise for healthcare professionals in remote areas.
Furthermore, the World Health Organization (WHO) recommended telemedicine and digital interventions to strengthen health systems. In 2020, Digital Implementation Investment Guide (DIIG) provided guidance on integrating digital interventions, while, in 2021, Global Strategy promoted their responsible adoption. These initiatives reflected WHO's commitment to leveraging telemedicine and digital health for stronger healthcare systems. Overall, teleconsultation will optimize workflow, manage higher case volumes, and address healthcare disparities, providing equitable access to pathology services.
The telepathology market by end-use is segregated into hospitals, academic & research institutes, and others. The hospitals segment accounted for over 54.7% industry share in the year 2022. The predominant presence of hospitals is driven by the demand for remote pathology expertise, seamless collaboration, and workflow optimization. These factors collectively contribute to improved patient care, enhanced diagnostics, and the overall gains of the industry within the hospital sector. Furthermore, the increasing incidence of chronic conditions such as cancer, cardiovascular diseases, and neurological disorders has led to a higher demand for pathology services in hospitals. This capability significantly enhances the management and treatment of these conditions within the hospital setting. These factors collectively contribute to improved patient care, enhanced diagnostic capabilities.
U.S. telepathology market accounted for USD 247.8 million revenue size in 2022. The telepathology industry in the U.S. is the increasing demand for efficient and timely pathology services. Additionally, the rapid advancement of digital imaging and communication technologies serves as a propelling factor for business in the U.S. For instance, digital pathology platforms and high-resolution imaging systems have become more accessible and user-friendly, allowing pathologists to capture and share high-quality images of tissue sample these images can be easily transmitted to remote experts for consultation and second opinions, enabling pathologists to tap into a wider network of expertise. These driving forces are reshaping the field of pathology, enabling pathologists to collaborate remotely, improve diagnostic accuracy, and deliver enhanced patient care.
Telepathology Market Share
Some of the eminent industry participants operating in the telepathology market include :
Telepathology Industry News:
Telepathology market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Product (USD Million & Units)
By Application (USD Million)
By End-use (USD Million)
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →